Publikationen von A. Sigal
Alle Typen
Zeitschriftenartikel (43)
2024
Zeitschriftenartikel
15 (1), 2003 (2024)
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants. Nature Communications 2023
Zeitschriftenartikel
8 (1) (2023)
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells. NPJ Vaccines
Zeitschriftenartikel
Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb. Infect Drug Resist, 16:3629-3638 (2023)
Zeitschriftenartikel
18 (3), S. 636 - 653 (2023)
SARS-CoV-2 infection of airway organoids reveals conserved use of Tetraspanin-8 by Ancestral, Delta, and Omicron variants. Stem Cell Reports 2022
Zeitschriftenartikel
7 (11), S. 1756 - 1761 (2022)
SARS-CoV-2 Omicron variant emerged under immune selection. Nature Microbiology
Zeitschriftenartikel
HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway. eLife, e79924 (2022)
Zeitschriftenartikel
75 (1) (2022)
Similar Antibody Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Individuals Living Without and With Human Immunodeficiency Virus on Antiretroviral Therapy During the First South African Infection Wave. Clinical Infectious Diseases
Zeitschriftenartikel
Association Between Human Immunodeficiency Virus Viremia and compromised Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Beta Variant. The Journal of Infectious Diseases (2022)
Zeitschriftenartikel
HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization. The Journal of Infectious Diseases (2022)
Zeitschriftenartikel
13 (1), 4686 (2022)
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. Nature Communications
Zeitschriftenartikel
18 (6), e1010592 (2022)
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes. PLoS Pathogens
Zeitschriftenartikel
Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature (2022)
Zeitschriftenartikel
22 (5), S. 267 - 269 (2022)
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections COMMENT. Nature Reviews Immunology
Zeitschriftenartikel
39 (2), 110650 (2022)
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells. Cell Reports
Zeitschriftenartikel
13 (1), 1976 (2022)
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage. Nature Communications
Zeitschriftenartikel
22, S. 267 - 269 (2022)
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections. Nature Reviews Immunology
Zeitschriftenartikel
602, S. 654 - 656 (2022)
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature
Zeitschriftenartikel
30 (2) (2022)
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell Host & Microbe
Zeitschriftenartikel
603 (7902), S. 706 - 714 (2022)
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature
Zeitschriftenartikel
603, S. 488 - 492 (2022)
T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature